Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients
A recent study published in the New England Journal of Medicine conducted a trial of lixisenatide to assess its effects in early Parkinson’s disease. Study: Trial of Lixisenatide in Early Parkinson’s Disease. …
Read guide →